Dose-related ethanol-like effects of the NMDA antagonist, ketamine, in recently detoxified alcoholics

Archives of General Psychiatry

Volumn 55, Issue 4, 1998, Pages 354-360

  Krystal, John H ^a   Petrakis, Ismene L ^a   Webb, Elizabeth ^a   Cooney, Ned L ^a   Karper, Laurence P ^a   Namanworth, Sheila ^a   Stetson, Philip ^b   Trevisan, Louis A ^a   Charney, Dennis S ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; CANNABIS; COCAINE; KETAMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

ADULT; ALCOHOL ABUSE; ALCOHOLISM; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DETOXIFICATION; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRINKING BEHAVIOR; DRUG EFFECT; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; NEUROTRANSMISSION; RANDOMIZED CONTROLLED TRIAL; RECEPTOR BLOCKING; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGE OF ONSET; ALCOHOLIC INTOXICATION; ALCOHOLISM; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; EMOTIONS; ETHANOL; EUPHORIA; HUMANS; INFUSIONS, INTRAVENOUS; KETAMINE; MALE; RECEPTORS, N-METHYL-D-ASPARTATE; TEMPERANCE;

EID: 0031945082     PISSN: 0003990X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archpsyc.55.4.354     Document Type: Article

References (65)

1. Tsai G, Gastfriend DR, Coyle JT. The glutamatergic basis of human alcoholism. Am J Psychiatry. 1995;152:332-340.
2. Nakanishi S. Molecular diversity of glutamate receptors and implications for brain function. Science. 1992;258:597-603.
3. Lovinger DM, White G, Weight FF. Ethanol inhibits NMDA-activated ion current in hippocampal neurons. Science. 1989;243:1721-1724.
4. Lovinger DM. White G. Weight FF. NMDA receptor-mediated synaptic excitation selectively inhibited by ethanol in hippocampal slices from adult rat. J Neurosci. 1990;10:1372-1379.
5. White G, Lovinger DM, Weight FF. Ethanol inhibits NMDA-activated current but does not alter GABA-activated current in an isolated adult mammalian neuron. Brain Res. 1990;507:332-336.
6. Dildy-Mayfield JE. Leslie SW. Mechanism of inhibition of N-methyl-D-aspartatestimulated increases in free intracellular Ca2+ concentration by ethanol. J Neurochem. 1991;56:1536-1543.
7. Simson PE, Criswell HE. Johnson DB, Hicks RE, Breese GR. Ethanol inhibits NMDA-evoked electrophysiological activity in vivo. J Pharmacol Exp Ther. 1991;257:255-231.
8. Trevisan L, Fitzgerald LW, Brose N, Gasic GP. Heinemann SF, Duman RS, Nestler EJ. Chronic ingestion of ethanol up-regulates NMDA R1 subunit immunoreactivity in rat hippocampus. J Neurochem. 1994;62:1635-1638.
9. Danysz W, Jankowska E, Glazewski S. Kostowski W. The involvement of NMDA receptors in acute and chronic effects of ethanol. Alcohol Clin Exp Res. 1992;16:499-504.
10. Grant KA, Valverius P, Hudspith M, Tabakoff B. Ethanol withdrawal seizures and the NMD receptor complex. Eur J Pharmacol. 1990;176:289-296.
11. lorio KR, Reinlib L, Tabakoff B, Hoffman PL. Chronic exposure of cerebellar granule cells to ethanol results in increased N-methyl-D-aspartate receptor function. J Pharmacol Exp Ther. 1992;41:1142-1148.
12. Fidecka S, Langwinski R. Interaction between ketamine and ethanol in rats and mice. Pol J Pharmacol. 1989;41:23-32.
13. Chandler LJ, Newsom H, Sumner C, Crews F. Chronic ethanol exposure potentiates NMDA excitotoxicity in cerebral cortical neurons, J Neurochem. 1993;60:1578-1581.
14. Grant KA, Knisely JS. Tabakoff B, Barrett JE, Balster RL. Ethanol-like discriminative stimulus effects of non-competitive N-methyl-D-aspartate antagonists. Behav Pharmacol. 1991;2:87-95.
15. Grant KA, Colombo G. Discriminative stimulus effects of ethanol, J Pharmacol Exp Ther. 1992;254:1241-1247.
16. Butelman ER, Baron SP, Woods JH, Ethanol effects in pigeons trained to discriminate MK-801, PCP or CGS-19755. Behav Pharmacol. 1993;4:57-60.
17. Schechter MD, Meehan SM, Gordon TL, McBurney DM. The NMDA receptor antagonist MK-801 produces ethanol-like discrimination in the rat. Alcohol. 1993;10:197-201.
18. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Third Edition, Revised. Washington, DC: American Psychiatric Association; 1987.
19. Spitzer RI, Williams JBW, Gibbon M, First MB. The Structured Clinical Interview for DSM-III-R, I: history, rationale, and description. Arch Gen Psychiatry. 1992;49:624-629.
20. Selzer ML, The Michigan Alcoholism Screening Test: the quest for a new diagnostic Instrument. Am J Psychiatry. 1971;127:1653-1658.
21. von Knorring AL, Bohman M, von Knorring L, Oreland L. Platelet MAO activity as a biological marker in subgroups of alcoholism. Acta Psychiatr Scand. 1985;72:51-58.
22. Krystal JH, Karper LP, Seibyl JP, Freeman GK, Delaney R, Bremmer JD, Heninger GR, Bowers MB Jr, Charney DS. Subanesthetic effects of the NMDA antagonist, ketamine, in humans, Arch Gen Psychiatry. 1994;51:199-214.
23. Krystal JH, Webb E, Cooney NL, Kranzler H, Charney DS. Specificity of ethanol-like effects elicited by serotonergic and noradrenergic mechanisms. Arch Gen Psychiatry. 1994;51:898-911.
24. Maisto SA, Conners GJ, Tucker JA, McCollam JB, Addesso VJ. Validation of the Sensation Scale, a measure of subjective physiological responses to alcohol. Behav Res Ther. 1980;18:37-43.
25. Martin CS, Earleywine M, Musty RE, Perrlne MW, Swift RM. Development and valldation of the Biphasic Alcohol Effects Scale. Alcohol Clin Exp Res. 1993;17:140-146.
26. Krystal JH,Karper LP, D'Souza DC, Abi-Dargham A, Morrissey K, Bremner JD, Heninger GR, Bowers MB, Suckow R, Charney DS. Interactive effects of subanesthetic ketamine and subhypnotic lorazepam in humans, Psychopharmacology. In press.
27. Colpaert FC, Niemegeers CJE, Janssen PAJ, Discriminative stimulus properties of cocaine. Pharmacol Biochem Behav. 1979;10:535-546.
28. Koek W, Colpaert FC, Woods JH, Kamenka J-M. The phencyclidine (PCP) analog N-(1-[2-benzo(B)thiophenyl]cyclohexyl) piperidine shares cocaine-like but not other characteristic behavioral effects with PCP, ketamine, and MK-801. J Pharmacol Exp Ther. 1989;250:1019-1027.
29. Benkelfat C, Murphy DL, Hill JL, George DT, Nutt D, Linnolla M. Ethanollike properties of the serotonergic partial agonist m-chlorophenylpiperazine in chronic alcoholic patients, Arch Gen Psychiatry. 1991;48:383.
30. Layer RT, Kaddis FG, Wallace L. The NMDA receptor antagonist MK-801 elicits conditioned place preference in rats. Pharmacol Biochem Behav. 1993;44:245-247.
31. Heberg LJ, Rose IC. The effect of MK-801 and other antagonists of NMDA-type glutamate receptors on brain-stimulation reward. Psychopharmacology. 1989;99:87-90.
32. Young AM, Woods JH, Maintenance of behavior by ketamine and related compounds in rhesus monkeys with different self-administration histories. J Pharmacol Exp Ther. 1981;218:720-727.
33. Koek W, Woods JH, Winger GD, MK-801, a proposed noncompetitive antagonist of excitatory ammo acid neurotransmission, produces phencyclidine-like behavioral effects in pigeons, rats and rhesus monkeys. J Pharmacol Exp Ther. 1988;245:969-974.
34. Siegel RK. Phencyclidine and ketamine intoxication: a study of four populations of recreational users. In: Petersen RC, Stillman RC, eds. Phencyclidine (PCP) Abuse: An Appraisal. Rockville, Md: National Institute on Drug Abuse; 1978:119-147. NIDA Research Monograph 21.
35. Litt MD, Cooney NL, Kadden RM, Gaupp L. Reactivity to alcohol cues and induced moods in alcoholics, Addict Behav, 1990;15:137-146.
36. Engle KB, Williams TK, Effect of an ounce of vodka on alcoholics' desire for al-cohol. Q J Stud Alcohol. 1972;33:1099-1105.
37. Ludwig AM. Wikler A. Stark L. The first drink.Arch Gen Psychiatry. 1974;30:539-547.
38. Hodgson R, Rankin H, Stockwell T. Alcohol dependence and the priming effect. Behav Res Ther. 1979;17:379-387.
39. Newlin D, Thomson J. Alcohol challenge in sons of alcoholics: a critical review and analysis. Psychol Bull. 1990;108:383-402.
40. Earleywine M. Confirming the factor structure of the Anticipated Biphasic Alcohol Effects Scale. Alcohol Clin Exp Res. 1994;18:861-866.
41. Perez-Reyes M, McDonald SA, Hicks RE, Interaction between ethanol and dextroamphetamine. Alcohol Clin Exp Res. 1992;16:75-81.
42. McDougle CJ, Krystal JH, Price LH, Heninger GR, Charney DS. Noradrenergic response to acute ethanol administration in healthy subjects: comparison with intravenous yohimbine. Psychopharmacoiogy. 1995;118:127-135.
43. Swift RM, Whelihan W, Kuznetsov O, Buongiorno G, Hsuing H. Naltrexone-induced alterations in human ethanol intoxication. Am J Psychiatry. 1994;151:1463-1467.
44. Overton DA. Comparison of ethanol, pentobarbital, and phenobarbital using drug vs drug discrimination training. Psychopharmacoiogy. 1977;53:195-199.
45. Signs SA, Schechter MD. The role of dopamine and serotonin receptors in the mediation of the ethanol interoceptive cue. Pharmacol Biochem Behav. 1985;30:55-64.
46. Garcha HS, Stolerman IP. Discrimination of a drug mixture in rats: role of training dose, and specificity. Behav Pharmacol. 1989;1:25-31.
47. De Vry J, Slanger JF. Effect of training dose on discrimination and cross-generalization of chlordlazepoxide. pentobarbital, and ethanol in the rat. Psychopharmacoiogy. 1986;88:341-345.
48. Wong EHF, Kemp JA, Priestley T, Knight AR, Woodruff GN, Iversen LL. The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist. Proc Natl Acad Sci U S A. 1986;83:7104-7107.
49. France CP, Moerschbaecher JM, Woods JH. MK-801 and related compounds in monkeys. J Pharmacol Exp Ther. 1991;257:727-773.
50. Sucher NJ, Awobuluyi M, Choi Y-B, Lipton SA. NMDA receptors from genes to channels. Trend Pharmacol Sci. 1996;17:348-355.
51. Smith DJ, Westfall DP, Adams JD. Ketamine interacts with opiate receptors as an agonist [abstract]. Anesthesiology. 1980;53:S-5.
52. Herling S, Coale EH, Hein DW, Winger G, Woods JH. Similarity of the discriminative stimulus effects of ketamine, cyclazocine, and dextrorphan in the pigeon. Psychopharmacology. 1982;73:286-291.
53. Smith DJ, Azzaro AJ, Zaldivar SB, Palmer S, Lee HS. Properties of the optical isomers and metabolites of ketamine on the high-affinity transport and catabolism of monoamines. Neuropharmacology. 1981;20:391-396.
54. Shannon HE, Pharmacological analysis of the phencyclidine-like discriminative properties of narcotic derivatives in rats. J Pharmacol Exp Ther. 1982;222:146-151.
55. Winter JC. The stimulus properties of morphine and ethanol. Psychopharmacologia. 1975;44:209-214.
56. Volpicelli JP, Watson NT, King AC, Sherman CE, O'Brien CP. Effect of naltrexone on alcohol "high" in alcoholics. Am J Psychiatry. 1995;152:613-615.
57. Javitt DC, Zukin SR. Recent advances in the phencyclidine model of schizophrenia. Am J Psychiatry. 1991;148:1301-1308.
58. Irufine M, Shimizu T, Nomoto M. Ketamine-induced hyperlocomotion associated with alteration of presynaptic components of dopamine neurons in the nucleus accumbens of mice. Pharmacol Biochem Behav. 1991;40:399-407.
59. Snell LD, Mueller ZL, Gannon RL, Sllverman PB, Jonson KM. A comparison between classes of drugs having phencyclidine-like behavioral properties on dopamine efflux in vitro and dopamine metabolism in vivo. J Pharmacol Exp Ther. 1984;231:261-269.
60. Krystal J, Karper L, Bennett A, Abi-Saab D, D'Souza C, Abi-Dargham A, Charney D. Modulating ketamine-induced thought disorder with lorazepam and haloperidol in humans [abstract]. SchizRes. 1995;15:156.
61. Sass H, Soyka M, Mann K, Zieglgansberger W. Relapse prevention by acamprosate: results from a placebo-controlled study on alcohol dependence. Arch Gen Psychiatry. 1996;53:673-680.
62. Whitworth AB, Fischer F, Lesch OM, Nimmerrichter A, Oberbauer H, Platz T, Potgieter A, Walter H, Fleischhacher WW. Comparison of acamprosate and placebo in long-term treatment of alcohol dependence. Lancet. 1996;347;1438-1442.
63. Lovinger DM, Zieglgansberger W. Interactions between ethanol and drugs acting on the NMDA-type glutamate receptor. Alcohol Clin Exp Res. 1996;20(suppl): 187A-191A.
64. Rabe CS, Tabakoff B. Glycine site-directed agonists reverse the actions of ethanol at the N-methyl-D-asparate receptor. Mot Pharmacol. 1990;38:753-757.
65. Woodward JJ, Gonzales RA. Ethanol inhibition of N-methyl-D-aspartate-stimulated endogenous dopamine release from rat striatal slices: reversal by glycine. J Neurochem. 1990;54:712-715.